2-Hydroxyestrone: the 'good' estrogen

in Journal of Endocrinology
Restricted access


The issue of the role of 2-hydroxyestrone (2-OHE1) in breast cancer has been the subject of considerable controversy as to whether it is carcinogenic or anticarcinogenic. The expanding data base outlined below is most consistent with the conclusion that 2-OHE1 is anticarcinogenic. In every experimental model in which 2-hydroxylation was increased, protection against tumors was achieved. Correspondingly, when 2-hydroxylation was decreased, an increase in cancer risk was observed. Even more dramatically, in the case of laryngeal papillomas induction of 2-hydroxylation with indole-3-carbinol (I3C) has resulted in inhibition of tumor growth during the time that the patients continue to take I3C or vegetables rich in this compound.

Journal of Endocrinology (1996) 150, S259–S265


      Society for Endocrinology

Article Information


All Time Past Year Past 30 Days
Abstract Views 56 56 26
Full Text Views 230 230 20
PDF Downloads 95 95 6


Related Articles


Google Scholar